SMID Biotechs Stalled but a Strong Week for Most Large Caps

  • Large CAPs biopharmas did better during a volaiile week for AI and NASDAQ.
  • SMIDs in a Red screen mode with XBI down 6%, IWM down 3%.
  • BIG Winners for the week:AMGN, BIIB, LLY, PFE.  ;XLV up 13.74% YTD.

Another Rotation week? AI trade is back?

SMID biotech stocks are coming back today as large caps take a rest. The XBI is coming back up 2.86%  along with some of our favorite SMID trades: DNTH, NTRA,PTGX,ROIV, SLDB, TWST, VYGR, XENE. A little more action in ARKG and I’ll go RISK ON!

Stil lworried about small cap action.

Large Cap Biopharmaceuticals before Q3 earnings

COMPANY TIcker P Mkt Cap % YTD RSI P 10/18 % WTD
$B
Abbvie ABBV 276.47 488 21 71 285.42 3.24
Amgen AMGN 414.87 2224 26.7 62.5 432.43 4.25
Gilead Sciences GILD 151.17 187 23 63.41 156.19 3.32
Johnson and J JNJ 261.44 630 26.3 43.7 255.56 -2.25
Eli Lilly LLY 1179 1110 9.73 63.33 1257 6.59
Merck MRK 145.6 359 38.3 52 145.95 0.24
Pfizer PFE 28.28 161 13.57 69.7 29.58 4.6
Vertex VRTX 510 129 12.5 43.8 499.74 -1.77
ARK GEnomic Rev ARKG 40.7 46.7 -8.97
iShares Biotech IBB 45.84 202 -2.18
State ST SPDR XBI 35.9 144.32 -6.15

Disclosure: LONG: ABBV, GILD, LLY, MRK, PFE, VRTX; New BIIB, IBB. 

Pin It on Pinterest